Skip to main content
NVDA-2.50%AAPL+2.41%GOOGL-0.06%MSFT+0.13%AMZN+0.15%TSM-0.95%SPCX+1.70%AVGO-0.01%META-0.04%TSLA-0.55%SKHY-3.93%MU-4.37%BRK-B-0.10%LLY+0.49%JPM-0.33%AMD-2.50%WMT+0.19%V-0.04%XOM+0.09%ASMLa-1.73%JNJ-0.03%INTC-4.17%MA-0.35%0700.HK-1.94%ORCL-1.87%1398.HK+0.79%BAC-0.42%ABBV+0.54%CSCO-0.50%CVX-0.32%COST+0.07%LRCX-3.81%KO+1.02%CAT-1.08%AMAT-2.33%0005.HK-0.78%AP2d-1.62%UNH-0.55%DELL-2.90%HSBA.L-1.21%MS-0.13%PG-0.26%GE-0.12%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.01%HD-0.97%GS-0.41%0939.HK+1.66%NZDJPY-2.64%AUDJPY-1.89%CHFJPY-1.63%USDJPY-1.46%NZDCAD-1.37%GBPJPY-1.36%EURNZD+1.35%EURJPY-1.34%GBPNZD+1.29%CADJPY-1.28%NZDUSD-1.21%NZDCHF-1.05%USDNOK+0.92%EURNOK+0.87%CHFNOK+0.79%AUDNZD+0.78%USDZAR+0.72%USDSEK+0.72%EURZAR+0.67%EURSEK+0.66%AUDCAD-0.64%NOKJPY-0.64%AUDDKK-0.60%CHFSEK+0.60%GBPZAR+0.59%EURAUD+0.57%GBPAUD+0.52%AUDSGD-0.48%AUDUSD-0.44%USDMXN+0.43%USDTHB+0.42%GBPTRY+0.41%CADCHF+0.32%GBPHKD+0.32%NZDSGD-0.32%GBPMXN-0.28%EURCHF+0.28%USDPLN+0.27%AUDCHF-0.27%AUDNOK+0.27%GBPCHF+0.25%EURPLN+0.22%USDCHF+0.18%USDSGD+0.16%USDCAD-0.16%USDILS+0.16%EURUSD+0.11%SGDJPY+0.11%EURSGD+0.11%USDTRY+0.11%GBPUSD+0.10%GBPCAD-0.09%EURCZK-0.09%NZDMXN-0.08%EURHKD-0.07%USDCNH+0.06%EURCAD-0.06%USDDKK+0.05%CHFSGD+0.04%USDCOP-0.04%EURGBP+0.04%EURCNH+0.03%GBPSGD+0.02%USDHKD+0.01%PLNJPY0.00%EURDKK0.00%XPTUSD-4.75%HG1-4.48%XAGUSD-4.06%GAGUSD-4.05%UKOIL+3.70%USOIL+3.27%SUGAR+1.85%COCOA+1.35%GAUUSD-0.81%XAUUSD-0.81%COTTON+0.75%S1+0.71%BTCUSD-1.44%ETHUSD-1.28%USDTUSD-0.02%XRPUSD-2.83%SOLUSD-1.70%TRXUSDT-0.03%ZECUSDT-6.04%DOGEUSD-3.19%XMRUSDT-2.27%LINKUSD-1.44%XLMUSD-2.08%BCHUSDT-10.82%LTCUSD-1.94%UNIUSD-3.79%TONUSD+24.88%HBARUSDT-2.01%SUIUSD-3.63%TAOUSDT-5.46%AAVEUSD-3.12%DOTUSDT-3.07%ICPUSDT-1.01%ONDOUSDT-3.17%WLDUSDT-2.91%ATOMUSDT-4.49%ARBUSDT+0.77%JUPUSDT-3.39%INJUSDT-4.98%STXUSDT-3.61%FETUSDT-3.89%TIAUSDT-1.39%PYTHUSDT-0.27%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-3.23%WIFUSDT-4.89%OPUSDT-4.00%IOTAUSDT-3.93%POLUSDT-5.63%AXSUSDT-2.90%FARTCOINUSDT-3.61%EOSUSDT-0.80%DYDXUSDT-1.06%ORDIUSDT-1.36%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.50%AAPL+2.41%GOOGL-0.06%MSFT+0.13%AMZN+0.15%TSM-0.95%SPCX+1.70%AVGO-0.01%META-0.04%TSLA-0.55%SKHY-3.93%MU-4.37%BRK-B-0.10%LLY+0.49%JPM-0.33%AMD-2.50%WMT+0.19%V-0.04%XOM+0.09%ASMLa-1.73%JNJ-0.03%INTC-4.17%MA-0.35%0700.HK-1.94%ORCL-1.87%1398.HK+0.79%BAC-0.42%ABBV+0.54%CSCO-0.50%CVX-0.32%COST+0.07%LRCX-3.81%KO+1.02%CAT-1.08%AMAT-2.33%0005.HK-0.78%AP2d-1.62%UNH-0.55%DELL-2.90%HSBA.L-1.21%MS-0.13%PG-0.26%GE-0.12%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX+0.01%HD-0.97%GS-0.41%0939.HK+1.66%NZDJPY-2.64%AUDJPY-1.89%CHFJPY-1.63%USDJPY-1.46%NZDCAD-1.37%GBPJPY-1.36%EURNZD+1.35%EURJPY-1.34%GBPNZD+1.29%CADJPY-1.28%NZDUSD-1.21%NZDCHF-1.05%USDNOK+0.92%EURNOK+0.87%CHFNOK+0.79%AUDNZD+0.78%USDZAR+0.72%USDSEK+0.72%EURZAR+0.67%EURSEK+0.66%AUDCAD-0.64%NOKJPY-0.64%AUDDKK-0.60%CHFSEK+0.60%GBPZAR+0.59%EURAUD+0.57%GBPAUD+0.52%AUDSGD-0.48%AUDUSD-0.44%USDMXN+0.43%USDTHB+0.42%GBPTRY+0.41%CADCHF+0.32%GBPHKD+0.32%NZDSGD-0.32%GBPMXN-0.28%EURCHF+0.28%USDPLN+0.27%AUDCHF-0.27%AUDNOK+0.27%GBPCHF+0.25%EURPLN+0.22%USDCHF+0.18%USDSGD+0.16%USDCAD-0.16%USDILS+0.16%EURUSD+0.11%SGDJPY+0.11%EURSGD+0.11%USDTRY+0.11%GBPUSD+0.10%GBPCAD-0.09%EURCZK-0.09%NZDMXN-0.08%EURHKD-0.07%USDCNH+0.06%EURCAD-0.06%USDDKK+0.05%CHFSGD+0.04%USDCOP-0.04%EURGBP+0.04%EURCNH+0.03%GBPSGD+0.02%USDHKD+0.01%PLNJPY0.00%EURDKK0.00%XPTUSD-4.75%HG1-4.48%XAGUSD-4.06%GAGUSD-4.05%UKOIL+3.70%USOIL+3.27%SUGAR+1.85%COCOA+1.35%GAUUSD-0.81%XAUUSD-0.81%COTTON+0.75%S1+0.71%BTCUSD-1.44%ETHUSD-1.28%USDTUSD-0.02%XRPUSD-2.83%SOLUSD-1.70%TRXUSDT-0.03%ZECUSDT-6.04%DOGEUSD-3.19%XMRUSDT-2.27%LINKUSD-1.44%XLMUSD-2.08%BCHUSDT-10.82%LTCUSD-1.94%UNIUSD-3.79%TONUSD+24.88%HBARUSDT-2.01%SUIUSD-3.63%TAOUSDT-5.46%AAVEUSD-3.12%DOTUSDT-3.07%ICPUSDT-1.01%ONDOUSDT-3.17%WLDUSDT-2.91%ATOMUSDT-4.49%ARBUSDT+0.77%JUPUSDT-3.39%INJUSDT-4.98%STXUSDT-3.61%FETUSDT-3.89%TIAUSDT-1.39%PYTHUSDT-0.27%SEIUSDT-3.91%IMXUSDT-3.85%GRTUSDT-3.23%WIFUSDT-4.89%OPUSDT-4.00%IOTAUSDT-3.93%POLUSDT-5.63%AXSUSDT-2.90%FARTCOINUSDT-3.61%EOSUSDT-0.80%DYDXUSDT-1.06%ORDIUSDT-1.36%GALAUSDT-4.78%NOTUSDT-2.97%RONINUSDT-2.64%
CO

CorMedix Inc. (CRMD)

NASDAQ • Healthcare

$8.13
-$0.04 (-0.6%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$8.18
Previous Close$8.13
Day Range$8.08 - $8.33
Avg. Volume (3M)1.4M
Market Cap$637.8M
P/E Ratio3.4
52 Week Range
$6.13$13.34
Next EarningsIn 62 daysNov 11, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$101.9M100%
Gross Profitminus cost of goods$77.1M76%
Operating Incomeminus R&D and overhead$42.9M42%
Net Incomeminus taxes and the rest$25.9M25%

In plain terms: out of every $100 in revenue, CorMedix Inc. keeps $25 as net profit.

Fundamentals & Financials

Revenue (TTM)
$462.2M
Net Income (TTM)
$187.1M
EPS (TTM)
$2.41
ROA (TTM)
20.7%
Current Ratio
2.56
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-79.1%Q1 2026$0.18
+22.9%Q2 2026$0.43
+21.8%Q3 2026$0.29
Next

Nov 11

in 62 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About CorMedix Inc.

CorMedix Inc. (NASDAQ: CRMD) is a healthcare biotechnology company centered on DefenCath/Neutrolin, an anti-infective solution used to protect catheter patients from infection and clotting. In FY2025, the company generated $311.7 million in revenue. CorMedix serves the United States and international markets from a business built around this single product platform.

Name
CorMedix Inc.
CEO
Joseph Todisco
Website
www.cormedix.com
Industry
Healthcare
Year Founded
2006
Employees
191

Today's Snapshot

AI-generated

CRMD opened slightly lower at 8.10, while its sector was flat.

Trading Volume

Below 10d avg (815.0K)

180.9K

vs S&P 500 Today

Underperforming Market

-1.08%

Updated: September 10, 2026 at 14:56 UTC

Technical Indicators

1 Buy2 Neutral5 Sell
CRMD at roughly $7.99 posts a Strong Sell reading driven by price pressure across most moving averages and negative volume dynamics. Short, medium and long moving averages are signaling weakness, momentum is tepid, and on-balance volume is substantially negative, reinforcing distribution. ADX around the mid-20s shows some trend strength to the downside while ATR reflects moderate volatility; both classic and Fibonacci pivots are aligned with resistance near current levels. Technical takeaway: Strong Sell.
All signals
  • EMA (5 indicators)$8.09 - $8.66
    Sell
  • RSI (14)46.61
    Neutral
  • Stochastic %K (14, 3, 3)10.60
    Buy
  • MACD Level (12, 26)0.08
    Neutral

Peers & Related Assets

TNGXTango Therapeutics, Inc.
$24+5.7%
PVLAPalvella Therapeutics, Inc.
$151.34-0.6%
SEPNSepterna Inc
$37.97+1.6%
BCAXBicara Therapeutics Inc. Common Stock
$23.64-0.3%
SVRASavara Inc.
$5.42-2.0%
KURAKura Oncology, Inc.
$12.09-3.4%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.